Latest Breaking News On - European instructions - Page 9 : comparemela.com
Hemanext Inc. Receives CE Mark Certification for Innovative Red Blood Cell (RBC) Processing & Storage System
Product now available in Norway, Blood centers in Italy, Switzerland, and
France expected to complete validations later this year
LEXINGTON, Mass., April 13, 2021 /PRNewswire/ Hemanext Inc., a privately held medical technology company, today announced it has received a CE Certificate of Conformity for the CE Mark for its Hemanext ONE Red Blood Cell (RBC) Processing and Storage System, allowing the innovative medical device to be sold in European markets. Blood center validations required for the adoption of the Hemanext ONE RBC Processing and Storage System were completed in Norway in 2020. The company expects blood centers in Italy, Switzerland, and France to complete validations in 2021. Hemanext plans to secure additional validations and approvals in order to make the device available to healthcare professionals in other select European markets and in the Americas i
Haugesund
Rogaland
Norway
Italy
United-states
France
Switzerland
Haukeland
Hordaland
American
Androulla-eleftheriou
Giuliano-grazzini
13 aprile 2021 | 10.01 LETTURA: 6 minuti
Company to launch Hemanext ONE® RBC Processing and Storage System in select European markets in 2021, with wider distribution in Europe and the Americas in 2022 and future years
Product now available in Norway, Blood centers in Italy, Switzerland, and France expected to complete validations later this year
LEXINGTON, Mass., April 13, 2021 /PRNewswire/ Hemanext Inc., a privately held medical technology company, today announced it has received a CE Certificate of Conformity for the CE Mark for its Hemanext ONE Red Blood Cell (RBC) Processing and Storage System, allowing the innovative medical device to be sold in European markets. Blood center validations required for the adoption of the Hemanext ONE RBC Processing and Storage System were completed in Norway in 2020. The company expects blood centers in Italy, Switzerland, and France to complete validations in 2021. Hemanext plans to secure additional validations
Haugesund
Rogaland
Norway
Italy
United-states
France
Switzerland
Haukeland
Hordaland
American
Androulla-eleftheriou
Giuliano-grazzini